• Report Adverse Event or Product Quality Complaint
  • Global Site
AstraZeneca Medical Information
  • Prescribing Information
  • Resources
    • Congress Library
    • Our Pipeline
    • AZ Clinical Trials
    • Externally Sponsored Scientific Research
  • Connect
    • Send MIR
    • Give Feedback

Search Medical Information

European Renal Association (ERA) - 62nd Congress - 2025

June 04 - 07, 2025

  1. Chronic Kidney Disease
  2. Hypertension
  3. Hyperkalaemia

pdf

Patient and carer treatment preferences for chronic kidney disease (CKD): a discrete choice experiment (DCE) across eight countries

pdf

Impact of targeted screening in high-risk individuals and guideline-directed medical therapy on CKD burden in Europe: Projections from IMPACT CKD

pdf

Evaluating the clinical and economic impact of SGLT-2 inhibitors for CKD management in the UK: Insights from the IMPACT CKD microsimulation model.

A patient-level simulation study assessing the clinical, economic, and environmental burden of chronic kidney disease in the Netherlands

pdf

Characteristics of patients with chronic kidney disease and inadequately controlled hypertension: Insights from the ENLIGHTN study

Insights into the adoption of consensus guidelines for hyperkalemia management in Spain: a national, multicenter, descriptive analysis

Baseline characteristics and decision-making in the management of hyperkalaemia by incident and recurrent Hyperkalaemia in Spain: Interim results from the prospective TRACK study

Need Help?

Contact Us

Send MIR

Submit a Medical Information Request

Disclaimer

Some content may have changed since publication. Some links may require registration/login to access the content. Any attached publications and/or any tables or figures derived from the publications are copyright-protected works. AstraZeneca has obtained permission from the copyright owner to use this work on this site. You may not reproduce, prepare derivative works from, display or distribute this work unless you obtain the permission of the copyright owner, or as otherwise might be permitted by law.

AstraZeneca Logo

This platform is provided as service to healthcare professionals by AstraZeneca Philippines, for medical educational purposes only.

©2024 AstraZeneca. All rights reserved.

PH-10554.

Last Updated 5/24

Contact Us

About Us

AstraZeneca.com

Survey Feedback

Privacy Notice

Legal Notice

Cookie Notice

Global Site

Report Adverse Event or Product Quality Complaint

Privacy NoticeLegal NoticeCookie Notice

Welcome to AstraZeneca Philippines Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the Philippines, for medical educational purposes only. AstraZeneca does not engage in the promotion of unregistered products or unapproved indications. The dissemination of this information may be subject to different medical and regulatory requirements in other countries

Are you a healthcare professional practicing in the Philippines?

No